Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin

Clinical trial NCT06592950 · COMPLETED

Trial details

NCT number: NCT06592950
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Type-2 Diabetes Mellitus (T2DM)

Start date: 2023-11-02
Primary completion: 2024-04-29
Enrollment: 513

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.